Themis Medicare Limited Board Approves Q2 FY27 Un-Audited Financial Results
Themis Medicare Limited's Board approved the Un-Audited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. The results were reviewed by statutory auditors. The Board meeting was held on November 14, 2026.
Disclosure of financial results is material information for investors and impacts the company's valuation and investment decisions.
The announcement is a routine disclosure of financial results as approved by the board. It does not contain any significant positive or negative news.
Themis Medicare Limited announced the outcome of its Board Meeting held on Saturday, 14th November, 2026. The Board of Directors considered and approved the Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September, 2026.
The Limited Review Reports from the Statutory Auditors, M/s. Krishaan & Co., Chartered Accountants, were also attached with the financial results.
The Board meeting commenced at 01:00 P.M. (IST) and concluded at 02:30 P.M. (IST).
What to do with a filing like this
Themis Medicare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Themis Medicare Limited. Read the original for the full detail.